Brief: Starpharma Confirms It Submitted Application To TGA For Antiviral Nasal Spray As Medical Device
04/03/2022 01:48
March 4 (Reuters) - Starpharma Holdings Ltd SPL.AX :
* STARPHARMA HOLDINGS LTD - CONFIRMS IT SUBMITTED
APPLICATION TO
AUSTRALIA'S TGA FOR ITS ANTIVIRAL NASAL SPRAY AS A MEDICAL
DEVICE
* STARPHARMA HOLDINGS LTD - REGULATORY PROCESS FOR
STARPHARMA'S
MEDICAL DEVICE APPLICATION IS ONGOING
Source text for Eikon: ID:nASX7sBD6z
Further company coverage: SPL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starpharma Holdings
See all newsBrief: Starpharma Increases Stake In Petalion To 66% Securing Majority Ownership
Brief: Starpharma Seeks Trading Halt
Brief: Starpharma Holdings Appoints Russell Basser As Chair
Brief: Starpharma Says Fully Underwritten Entitlement Offer To Raise A$32 MLN
Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising